ScholarLens Back to search
1998•PharmacoEconomicsRequires access

Cost Analysis of the Treatment of Schizophrenia in the UK

Stephen Almond, Owen O???Donnell

Open publisher page 72 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 72 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Olanzapine, Haloperidol, Psychiatry, Medicine, Schizophrenia (object-oriented programming), Health economics, Psychology, Public health

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Cost Analysis of the Treatment of Schizophrenia in the UK — Research Paper | ScholarLens